Salesforce Inc (NYSE:CRM, ETR:FOO) is set to deliver first-quarter revenue in line with guidance, but investors should expect limited upside on remaining performance obligations and conservative comments from management, according to analysts at Jefferies. The company will hand down its fiscal Q1 earnings for the three months ending in April on Wednesday, May 28, after markets close.

Known Tesla bull Dan Ives sees a ‘golden age' for Tesla based on AI and AVs, but that optimistic view faced a colder reality of trade-war fears.

Business development companies, or BDCs, are inherently risk-on assets that operate in a volatile segment (private credit). In most cases they do not go well together with retirement income portfolios. Yet, there are some rare exceptions.

Advance Auto Parts, Inc. AAP posted better-than-expected first-quarter financial results on Thursday.

Mike Shorr with @ProsperTradingAcademy focuses on three companies with expansive reach in ecommerce and digital advertising. He notes Maplebear (CART) brushing up against a key resistance level, Roku Inc.'s (ROKU) vulnerability of "outperforming to the downside," and his bullish expectations on Amazon (AMZN).

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=150011&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150008&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=150009&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150012&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=150007&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Baidu, Inc. reported strong Q1 results, but soft advertising revenue weighed on stock performance. Investors are likely concerned that economic headwinds in China will continue to impact near-term earnings visibility. AI-related endeavors, accomplishments and BIDU spending remain strong, which is both an opportunity and a further burden on earnings.

While Keysight is well-positioned for secular growth (6G, AI), the current stock price may already reflect much of this future optimism, limiting the immediate upside. Keysight's stock (around $161.74) appears to have a high forward P/E of 24x, potentially outpacing its "gradual recovery" forecast. The pending Spirent LSA acquisition (closing Q3'25) offers software growth potential but also brings integration complexities and execution risks to watch closely.

Despite the lack of cautious enthusiasm from retail investors in Teva, it continues to beat consensus estimates by wide margins and has once again raised its 2025 financial guidance. I highlight Austedo, Uzedy, the launch of biosimilars, and the more than successful development of duvakitug for the treatment of IBD in collaboration with Sanofi as key growth drivers. Moody's and Fitch also recently raised the Israeli pharmaceutical giant's credit ratings thanks to the continued strengthening of its balance sheet.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Central Pacific Financial (CPF) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Penske Automotive (PAG) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eagle Bancorp Montana, Inc. (EBMT) have what it takes?

MILPITAS, Calif.--(BUSINESS WIRE)---- $CRSR--Corsair Gaming, Inc. (Nasdaq: CRSR) (“Corsair” or the “Company”), a leading global provider and innovator of high-performance products for gamers, streamers, content-creators, and gaming PC builders, today announced it will present to institutional investors at TD Cowen's 53rd Annual Technology, Media & Telecom Conference on May 28, 2025, at the InterContinental New York Barclay in New York, NY. A live fireside webcast with management will be available thr.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Barclays (BCS) have what it takes?